Skip to main content

Table 3 Association of level of support offered to patients and clinical outcomes

From: Severe hyperkalemia requiring hospitalization: predictors of mortality

 

Improvement in hyperkalemia

In-hospital mortality

 

Improvement

( n = 715)

No improvement

( n = 208)

P

Death

( n = 283)

Survival

( n = 640)

P

Level of

support Ia

2.8 ± 1.8

2.2 ± 1.5

< 0.001

2.4 ± 1.5

2.7 ± 1.8

0.012

Level of

support IIb

3.1 ± 1.9

2.6 ± 1.8

< 0.001

2.9 ± 1.9

3.0 ± 1.9

0.266

  1. Values are presented as mean ± standard deviation. aDefined as the sum of weighted value for initial conservative management offered to each patient, including drug cessation (weight 1), intravenous (IV) calcium gluconate (weight 1), dextrose fluid with insulin (weight 1), IV or oral sodium bicarbonate (weight 1), calcium polystyrene sulfonate enema (weight 1), oral calcium polystyrene sulfonate (weight 1), and IV or oral loop diuretics (weight 1). bDefined as the sum of weighted value for initial conservative management and renal replacement therapy offered to each patient, including hemodialysis (weight 1) and continuous renal replacement therapy (weight 2).
Back to article page

Critical Care

ISSN: 1364-8535